Pathogenic variants in the SLC2A1 gene cause Glucose Transporter 1 deficiency and decreased glucose concentration in the central nervous system leading to a variety of severe neurological symptoms, including ID, epilepsy, and dystonia. The gene discussed is SLC2A1; the disease is epilepsy.